As we approach 2025, the landscape of business operations is rapidly evolving, driven by new artificial intelligence (AI) automation trends. These innovations are not just incremental improvements; ...
On the cusp of a new year, enterprise IT faces a fascinating conundrum: One of the least automated functions in any company is IT itself. I expect that to change, though it won’t always make for a ...
Artificial intelligence is transforming how we live and work, from personalized recommendations to health care innovation.
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has been positioned by Gartner, Inc. as a Leader in the 2025 Gartner® Magic Quadrant™ for ...
Dow has a diverse portfolio of manufacturing chemical and power plants and a rich heritage of process automation to run them. As facilities grow and expand, they tend to accumulate a wide range of ...
With artificial intelligence (AI) advancing rapidly, there needs to be more clarity about what generative AI means for process automation. After all, process automation has been around for decades, ...
The integration of generative AI (GenAI) into tools such as cloud-based SaaS (software-as-a-service) products are driving dynamic transformation in the industrial automation space. The emergence of ...
If you separately ask 10 industrial automation experts what the hottest trends of the moment are, you’ll likely get 10 different answers depending on the technologies they work with and in which ...
In the evolving world of marketing, automation has long been heralded as a game-changer. However, as businesses strive for greater efficiency and impact, a shift is taking place – from automating ...
Aerospace and Mechanical Insider on MSN

Assembly automation market driven by IoT and 5G

The global assembly automation market, valued at USD 56.17 billion in 2024, is projected to reach USD 121.16 billion by 2033, registering a compound annual growth rate of 8.9% from 2025 to 2033.
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...